Focus Area: Neuromuscular Diseases
Neuromuscular Diseases (e.g., Duchenne Muscular Dystrophy)
Not SpecifiedResearch & Development Focus
Key Facts
Indication
Neuromuscular Diseases (e.g., Duchenne Muscular Dystrophy)
Phase
Not Specified
Status
Research & Development Focus
Company
About Santhera Pharmaceuticals
Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company committed to addressing the needs of patients with rare neuromuscular diseases, with a primary focus on Duchenne muscular dystrophy (DMD). The company has dedicated over a decade to researching potential treatments for conditions that currently lack therapeutic options. Santhera's mission centers on making effective medicines available to improve patients' quality of life, with a vision to become a leader in the rare disease treatment landscape.
View full company profile